Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Back
Association details:
Biomarker:
TMB-H
Cancer:
Testicular Seminoma
Regimen:
(cisplatin + ifosfamide + paclitaxel)
Direction:
Sensitive
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
New
Source:
NCCN
Excerpt:
...if the residual disease is completely resected and histopathology shows viable seminoma, 2 cycles of adjuvant chemotherapy with the following regimens: EP, TIP (paclitaxel, ifosfamide, cisplatin)…
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login